Furosemide

Furosemide is a potent diuretic of the loop class, the group of agents that act on the ascending limb of the loop of Henle and produce the largest urine output of any diuretic type ^[1][2]. Chemically it is an anthranilic acid derivative carrying a sulfonamide group, with the molecular formula C12H11ClN2O5S ^[1]. When swallowed its absorption is notably variable and often incomplete, so the amount reaching the bloodstream can differ considerably from one person, or even one occasion, to the next; in the blood it is almost entirely bound to the protein albumin, and it is carried to its site of action in the kidney by a transport system that actively secretes organic acids into the urine ^[2]. Its diuretic effect tracks the amount of drug reaching the urine rather than its level in the blood, and because it acts and clears quickly its action is relatively brief ^[2].

The drug was patented in 1959 and came into medical use during the 1960s, receiving approval in the United States in 1964 ^[1]. It has remained a mainstay of treatment ever since and is marketed under many names, the best known being Lasix ^[1]. It is among the most commonly prescribed medications; in the United States it ranked among the thirty most prescribed drugs in the early 2020s, and it is included on the World Health Organization's List of Essential Medicines ^[1].

Furosemide is used chiefly to relieve the fluid overload, or oedema, that accompanies heart failure, kidney disease including the nephrotic syndrome, and cirrhosis of the liver, and it is also used to treat high blood pressure ^[1][2]. Because it can be given into a vein for a fast effect, it has a role in urgent situations such as fluid on the lungs, and it is sometimes used to help manage a high blood calcium level ^[1]. Long the default loop diuretic, it was compared directly with the related drug torsemide in the large TRANSFORM-HF trial in patients discharged after hospitalisation for heart failure; over the following year the two produced no significant difference in deaths, supporting the continued first-line use of furosemide ^[3]. A recognised practical drawback is the erratic and incomplete absorption of the oral form, which can make the response to a given dose hard to predict ^[2].

Most of furosemide's adverse effects are direct extensions of its powerful action on salt and water ^[2]. By driving off fluid it can cause dehydration and low blood pressure, and by increasing the loss of electrolytes in the urine it can lower blood levels of potassium, sodium, magnesium, and calcium, disturbances that call for monitoring ^[1][2]. It can also raise uric acid, sometimes provoking gout, and increase blood sugar ^[1]. A particular concern is ototoxicity; at high doses or when infused rapidly the drug can cause ringing in the ears or hearing loss, usually reversible, and a long-term population study linked loop diuretic use to a modestly increased risk of hearing loss in older adults ^[1][4]. Furosemide is available as tablets, an oral solution, and a solution for injection into a vein or muscle, so the route can be matched to how quickly an effect is needed ^[1].

Furosemide is a potent loop diuretic, and its main risks are volume depletion, dehydration, and electrolyte disturbances, notably low potassium, sodium, and magnesium, which can cause weakness, cramps, and cardiac arrhythmias. It can lower blood pressure, worsen kidney function if over-diuresed, raise uric acid and blood glucose, and cause dose-related hearing effects (ototoxicity) at high or rapid intravenous doses. Electrolytes, hydration, and kidney function should be monitored during use.

Furosemide interacts with NSAIDs and ACE inhibitors through pharmacodynamic mechanisms centered on renal function and electrolyte balance. NSAIDs reduce furosemide's diuretic and natriuretic effects by inhibiting prostaglandin synthesis, and concomitant use increases the risk of acute kidney injury ^[20]. This is a pharmacodynamic interaction where the NSAID dampens furosemide's renal effects. ACE inhibitors or angiotensin receptor blockers combined with furosemide increase nephrotoxicity risk, particularly in patients with renal impairment or diabetes ^[21]; this interaction arises because ACE inhibitors reduce aldosterone secretion.

Both interactions are clinically relevant; the risk depends on baseline renal function and serum electrolytes. Loop diuretics including furosemide also increase ototoxicity risk when used with aminoglycoside antibiotics or cisplatin, though this is poorly studied at modern doses. Interactions with other diuretics (spironolactone) affecting sodium and potassium levels remain incompletely characterized in controlled studies.

Checking a whole stack? Run it through interactions + stacks.

Furosemide was synthesised in 1962 by researchers at the German company Hoechst, who were exploring sulfonamide derivatives in the search for more powerful diuretics. It was introduced clinically in 1964 under the brand name Lasix, a name commonly said to derive from the phrase lasts six hours, a reference to its duration of action. Acting on the thick ascending limb of the loop of Henle, it proved far more potent than the thiazide diuretics that preceded it, capable of producing a brisk diuresis even in patients with impaired kidney function. This power quickly made it indispensable for conditions marked by fluid overload, from acute pulmonary oedema to heart failure, cirrhosis, and kidney disease. Decades later furosemide remains one of the most widely prescribed medicines in the world and appears on the World Health Organization's List of Essential Medicines.

Furosemide is regarded as a true workhorse of medicine, trusted for its speed and reliability; given intravenously it can relieve the breathlessness of acute pulmonary oedema within minutes, an effect few other drugs can match. Its long track record, low cost, and flexibility across oral and intravenous routes have kept it central to the management of fluid overload for more than half a century. Physicians are nonetheless clear-eyed about its liabilities: it can deplete potassium, sodium, and magnesium, its oral absorption varies considerably between patients, and very high or rapidly infused doses carry a risk of hearing damage. It is also banned in many sports and in horse racing, both as a masking agent and for rapid weight loss. Handled with appropriate monitoring, however, it remains one of the most valuable and dependable tools in clinical practice.